New weight-loss pill approved for use in UK
Foundayo is made by Eli Lilly, the drug firm behind the Mounjaro jab.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"While the weight-loss benefits of Foundayo were less than other treatments, patients could still expect to see 'significant, clinically meaningful changes to their weight'."
— Dr Simon Cork , Academic
"'The arrival of another effective oral option is a positive development and should help more people access treatment that best suits their needs and preferences.'"
— Prof Naveed Sattar , Academic
Key People
Locations
All Coverage
Foundayo is made by Eli Lilly, the drug firm behind the Mounjaro jab.
Similar Stories
Related coverage based on topic and tags
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMNovo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PMNovo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AMUS FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PM